The FDA announced on Sept. 9, 2021, that RaySearch Laboratories AB is recalling TomoHelical and TomoDirect plans in RayStation software versions 6 through 11A due to potential unexpected jaw position changes during treatment planning. The agency issued recall number Z-0848-2022 for the voluntary Class II action affecting 51 licenses distributed nationwide.
How to tell if you have it
- Brand: RaySearch Laboratories
- Product: TomoHelical and TomoDirect plans in RayStation 6, 7, 8A, 8B, 9A, 9B, 10A, 10B and 11A
- Build Numbers: 6.1.1.2, 6.2.0.7, 6.3.0.6, 7.0.0.19, 8.0.0.61, 8.0.1.10, 8.1.0.47, 8.1.1.8, 8.1.2.5, 9.0.0.113, 9.1.0.933, 9.2.0.483, 10.0.0.1154, 10.0.1.52, 10.1.0.613, 11.0.0.951 or 11.0.1.29
- Distribution: US Nationwide in AL, CA, FL, GA, IA, IL, MO, MS, NC, OK, OR, SC, TN, WA, WI
- Units affected: 51 licenses
The hazard
According to the FDA, if the dynamic jaw mode is used and an optimization is continued after changing the dose grid or modifying the target ROI, the positions of the jaws may change unexpectedly for some control points. The record states that users must be aware to avoid unnecessary jaw openings during treatment planning.
Context
GovInfoNow's records show RaySearch Laboratories AB has issued 36 other recalls since July 17, 2017. Recent brand recalls include a May 20, 2026 recall for RayCare 2:024A SP1 Oncology Software due to data loss risk and an Aug. 8, 2025 recall for RayStation Software regarding unique DICOM UIDs causing data conflicts. Other recent recalls of similar products include the Dec. 12, 2025 Elekta Leksell GammaPlan 11.1 Software Recall for risk of incorrect patient irradiation and the Feb. 6, 2026 Hitachi Proton Beam Therapy System Recall for positioning software anomaly risk.